GENFIT (EPA:GNFT) | WebDisclosure

Basculer en Français

9820	Companies
197077	Keywords
128165	Articles
104819	Press releases

Home
Companies
GENFIT

PRESS RELEASE

published on 06/10/2024 at 23:22, 1 year 7 months ago

GENFIT : Étape historique franchie avec l'approbation accélérée d'Iqirvo® d’Ipsen dans la Cholangite Biliaire Primitive par la FDA américaine
GENFIT franchit une étape historique avec l'approbation accélérée d'Iqirvo par la FDA américaine pour la Cholangite Biliaire Primitive en partenariat avec Ipsen

Approbation Accélérée Cholangite Biliaire Primitive GENFIT Iqirvo FDA Américaine
PRESS RELEASE

published on 06/10/2024 at 23:22, 1 year 7 months ago

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis
GENFIT achieves historic milestone with U.S. FDA accelerated approval of Ipsen's Iqirvo® for Primary Biliary Cholangitis. Elafibranor tablets approved as first-in-class treatment, marking a significant development in rare liver disease treatment landscape

Primary Biliary Cholangitis GENFIT Ipsen Iqirvo FDA Accelerated Approval
BRIEF

published on 05/29/2024 at 22:15, 1 year 8 months ago

GENFIT to Present Latest ACLF Research at EASL Congress™ 2024

Research Collaboration GENFIT ACLF EASL Congress Liver Disease
BRIEF

published on 05/29/2024 at 22:15, 1 year 8 months ago

GENFIT présentera ses dernières recherches sur l'ACLF au congrès EASL™ 2024

Collaboration En Recherche GENFIT ACLF Congrès De L'EASL Maladie Du Foie
PRESS RELEASE

published on 05/29/2024 at 22:10, 1 year 8 months ago

GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
GENFIT to present latest ACLF research at EASL Congress™ 2024, showcasing collaborative efforts with EF CLIF to advance understanding of ACLF pathophysiology and treatment approaches

Liver Diseases GENFIT ACLF Research EASL Congress 2024 EF CLIF Partnership
PRESS RELEASE

published on 05/29/2024 at 22:10, 1 year 8 months ago

GENFIT présentera ses dernières avancées dans l'ACLF à l'EASL Congress™ 2024
GENFIT présente ses avancées dans l'ACLF au congrès EASL 2024, détaillant un partenariat de recherche avec l'EF CLIF et des programmes de recherche dans l'ACLF, mettant en avant le potentiel de transformation du traitement

Recherche Traitement GENFIT ACLF EASL
BRIEF

published on 05/14/2024 at 22:15, 1 year 8 months ago

GENFIT Announces Q1 2024 Financials and Projects Cash Runway into Late 2025

Cash Position Clinical Trials Revenue Decline Biopharmaceutical Industry GENFIT Financial Results
BRIEF

published on 05/14/2024 at 22:15, 1 year 8 months ago

GENFIT annonce ses résultats financiers du premier trimestre 2024 et dispose d'une trésorerie disponible jusqu'à fin 2025

Industrie Biopharmaceutique Essais Cliniques Baisse Des Revenus Résultats Financiers De GENFIT Situation De Trésorerie
PRESS RELEASE

published on 05/14/2024 at 22:10, 1 year 8 months ago

GENFIT Reports First Quarter 2024 Financial Information
GENFIT reports Q1 2024 financial information showing cash position of €74.0 million and revenues of €1.1 million. Company expects cash to fund operations until Q4 2025

Financial Information Revenues Cash Position Q1 2024 GENFIT
PRESS RELEASE

published on 05/14/2024 at 22:10, 1 year 8 months ago

GENFIT : Information financière du premier trimestre 2024
GENFIT annonce sa situation de trésorerie au 31 mars 2024 et son chiffre d'affaires du premier trimestre 2024, avec des revenus en baisse par rapport à 2023

Chiffre D'affaires Biopharmaceutique Trésorerie Maladies Rares GENFIT

Accesswire

Published on 02/07/2026 at 01:00, 6 hours 5 minutes ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 7 hours 55 minutes ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 9 hours 4 minutes ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 15 hours 35 minutes ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 17 hours 35 minutes ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/06/2026 at 19:25, 11 hours 39 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 13 hours 13 minutes ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 17:40, 13 hours 25 minutes ago

Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.26.
Published on 02/06/2026 at 16:55, 14 hours 10 minutes ago

GAC MPV Serves as Official Reception Fleet for APEC China 2026, Demonstrating the Strength of Chinese Manufacturing
Published on 02/06/2026 at 15:25, 15 hours 40 minutes ago

CES 2026 Innovation Award Honoree iGarden M1 Pro Max Launches as World's First Bionic Dual-Vision Pool Cleaner

Les Echos

Published on 02/06/2026 at 18:22, 12 hours 43 minutes ago

Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 12 hours 43 minutes ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 15 hours 4 minutes ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 15 hours 4 minutes ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 23 hours 11 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026

View all LES ECHOS COMFI WIRE